Rho/Rho kinase as a potential target for the treatment of renal disease

Shu Wakino, Takeshi Kanda, Koichi Hayashi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The small G-protein Rho and its downstream effector Rho kinase constitute important mediators not only of vascular contraction but also of actin cytoskeleton reorganization, cellular morphology, motility, adhesion and proliferation. The Rho/Rho kinase pathway plays an important role in the structure and function of various kidney cells including tubular epithelial cells, mesangial cells and podocytes. The Rho/Rho kinase pathway also regulates glomerular blood flow and glomerular filtration rate by modulating renal arteriolar contractility. Potent and specific inhibitors of Rho kinase have recently been developed and their therapeutic effects on a variety of renal injury models have been examined. In the rat models of hypertensive glomerulosclerosis, unilateral ureteral obstruction (for interstitial renal fibrosis) and ischemia/reperfusion acute renal failure, treatment with novel Rho kinase inhibitors attenuates the development of renal damage. Although human data connecting the activation of Rho/Rho kinase pathway and kidney disease are still lacking, these studies have provided compelling evidence for the renoprotective effects of Rho kinase inhibitors.

Original languageEnglish
Pages (from-to)639-643
Number of pages5
JournalDrug News and Perspectives
Volume18
Issue number10
DOIs
Publication statusPublished - 2005 Dec

Fingerprint

rho-Associated Kinases
Kidney
Ureteral Obstruction
Podocytes
Mesangial Cells
Monomeric GTP-Binding Proteins
Kidney Diseases
Therapeutic Uses
Glomerular Filtration Rate
Actin Cytoskeleton
Acute Kidney Injury
Reperfusion
Blood Vessels
Fibrosis
Ischemia
Epithelial Cells
Wounds and Injuries

ASJC Scopus subject areas

  • Pharmacology

Cite this

Rho/Rho kinase as a potential target for the treatment of renal disease. / Wakino, Shu; Kanda, Takeshi; Hayashi, Koichi.

In: Drug News and Perspectives, Vol. 18, No. 10, 12.2005, p. 639-643.

Research output: Contribution to journalArticle

@article{6d72acf7104540ebbad4af7dced5a6a3,
title = "Rho/Rho kinase as a potential target for the treatment of renal disease",
abstract = "The small G-protein Rho and its downstream effector Rho kinase constitute important mediators not only of vascular contraction but also of actin cytoskeleton reorganization, cellular morphology, motility, adhesion and proliferation. The Rho/Rho kinase pathway plays an important role in the structure and function of various kidney cells including tubular epithelial cells, mesangial cells and podocytes. The Rho/Rho kinase pathway also regulates glomerular blood flow and glomerular filtration rate by modulating renal arteriolar contractility. Potent and specific inhibitors of Rho kinase have recently been developed and their therapeutic effects on a variety of renal injury models have been examined. In the rat models of hypertensive glomerulosclerosis, unilateral ureteral obstruction (for interstitial renal fibrosis) and ischemia/reperfusion acute renal failure, treatment with novel Rho kinase inhibitors attenuates the development of renal damage. Although human data connecting the activation of Rho/Rho kinase pathway and kidney disease are still lacking, these studies have provided compelling evidence for the renoprotective effects of Rho kinase inhibitors.",
author = "Shu Wakino and Takeshi Kanda and Koichi Hayashi",
year = "2005",
month = "12",
doi = "10.1358/dnp.2005.18.10.959578",
language = "English",
volume = "18",
pages = "639--643",
journal = "Drug News and Perspectives",
issn = "0214-0934",
publisher = "Prous Science",
number = "10",

}

TY - JOUR

T1 - Rho/Rho kinase as a potential target for the treatment of renal disease

AU - Wakino, Shu

AU - Kanda, Takeshi

AU - Hayashi, Koichi

PY - 2005/12

Y1 - 2005/12

N2 - The small G-protein Rho and its downstream effector Rho kinase constitute important mediators not only of vascular contraction but also of actin cytoskeleton reorganization, cellular morphology, motility, adhesion and proliferation. The Rho/Rho kinase pathway plays an important role in the structure and function of various kidney cells including tubular epithelial cells, mesangial cells and podocytes. The Rho/Rho kinase pathway also regulates glomerular blood flow and glomerular filtration rate by modulating renal arteriolar contractility. Potent and specific inhibitors of Rho kinase have recently been developed and their therapeutic effects on a variety of renal injury models have been examined. In the rat models of hypertensive glomerulosclerosis, unilateral ureteral obstruction (for interstitial renal fibrosis) and ischemia/reperfusion acute renal failure, treatment with novel Rho kinase inhibitors attenuates the development of renal damage. Although human data connecting the activation of Rho/Rho kinase pathway and kidney disease are still lacking, these studies have provided compelling evidence for the renoprotective effects of Rho kinase inhibitors.

AB - The small G-protein Rho and its downstream effector Rho kinase constitute important mediators not only of vascular contraction but also of actin cytoskeleton reorganization, cellular morphology, motility, adhesion and proliferation. The Rho/Rho kinase pathway plays an important role in the structure and function of various kidney cells including tubular epithelial cells, mesangial cells and podocytes. The Rho/Rho kinase pathway also regulates glomerular blood flow and glomerular filtration rate by modulating renal arteriolar contractility. Potent and specific inhibitors of Rho kinase have recently been developed and their therapeutic effects on a variety of renal injury models have been examined. In the rat models of hypertensive glomerulosclerosis, unilateral ureteral obstruction (for interstitial renal fibrosis) and ischemia/reperfusion acute renal failure, treatment with novel Rho kinase inhibitors attenuates the development of renal damage. Although human data connecting the activation of Rho/Rho kinase pathway and kidney disease are still lacking, these studies have provided compelling evidence for the renoprotective effects of Rho kinase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=33645063200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645063200&partnerID=8YFLogxK

U2 - 10.1358/dnp.2005.18.10.959578

DO - 10.1358/dnp.2005.18.10.959578

M3 - Article

VL - 18

SP - 639

EP - 643

JO - Drug News and Perspectives

JF - Drug News and Perspectives

SN - 0214-0934

IS - 10

ER -